NHSX announces five Accelerator SMEs as winners of the Adoption Fund
NHSX launched the Adoption Fund for innovations that support priorities around elective recovery and that have the potential for a wider roll-out across the NHS. The fund will provide over £6.5 million in funding across 35 different projects. Five Accelerator companies, getUBetter, DrDoctor, Ampersand Health, Concentric Health and Patients Know Best were announced as winners of the fund.
Gloucestershire CCG will be implementing the getUBetter platform to provide patient support and self-management of common MSK conditions through the availability of dedicated resources that are mapped to local population needs. Gloucestershire CCG will also work to ensure that social prescribing is incorporated within local MSK pathways on the platform.
We are excited to be providing digitally enabled MSK pathways across the Gloucestershire region via the getUBetter platform – digital tools have never been more important to support patients, clinicians and health providers. We’re looking forward seeing the real-world benefits of the solution across the region and helping patients to self-manage their new or recurrent musculoskeletal problems – becoming an active participant in their own care. Thank you to the DigitalHealth.London Accelerator team for their guidance in the refinement and testing of our value proposition to meet NHS needs.Carey McClellan, CEO, getUbetter
Liverpool University Hospitals NHS Foundation trust will be piloting the use of home faecal calprotectin (FC), in conjunction with DrDoctor tool, within three different groups of IBD patients. The aim is to increase return rate of FC results, decrease the amount of journeys patients have to make and improve follow up times for patients.
Ampersand Health: My IBD Care app
Integrating e-Health into the IBD patient pathway using virtual monitoring and faecal calprotectin home testing: Our Health South East London, in conjunction with its partners, plan to implement a three pronged project to enable at home monitoring for IBD patients in remission. Patients will be offered a virtual review via the My IBD Care app, with monthly calprotectin testing. The aim of this project is to reduce face to face appointments within this cohort, provide safe self monitoring for disease activity, ensure patients can trigger follow up interactions with the direct care team and to reduce the use of endoscopy resources.
Supported self-management and remote monitoring of IBD patients: Herefordshire and Worcestershire CCG plan to implement the use of the My IBD Care app and home faecal calprotectin tests to enable at home monitoring for IBD patients in Wye Valley. The aim of this project is to increase patient empowerment and experience, reduce unnecessary appointments, increase clinical capacity and effective prioritisation of patients.
IBD Home: Patient initiated supported self-management care model: Humber, Coast and Vale Health and Care Partnership plans to pilot the use of the My IBD Care app and home faecal calprotectin tests within two different IBD patient cohorts in Hull University Teaching Hospitals. The project aims to reduce: the number of routine outpatient appointments, emergency hospitalisations and admissions, excess steroid use and also improve patient engagement and satisfaction scores.
Establishing an integrated PIFU assessment service for stable IBD patients: Greater Manchester are planning to implement a patient pathway for IBD patients which will introduce a patient initiated follow up navigator to provide support and guidance for patients on this pathway. The pathways will use the My IBD Care app and home calprotectin tests to allow for patient self management and symptom based follow ups.
Buckinghamshire, Oxfordshire and Berkshire West ICS will be working with four different providers, one of which is Concentric Health, to implement and scale up digital innovations within the perioperative pathway. The four chosen evidence-based technology providers have previously shown potential in transforming the perioperative care pathway. The Oxford AHSN will then evaluate implementation and based on the evaluation outcomes, implementation will be spread across ICS providers and extended into other high-volume low complexity pathways.
“We are delighted to be involved in the work with the Buckinghamshire, Oxfordshire and Berkshire West Integrated Care System, building on our recent work at Oxford University Hospital. This is an exciting initiative to be a part of, bringing together leading technologies not only from the UK but globally to re-imagine a perioperative pathway that transforms both the experience and outcomes of surgical patient pathways. We are grateful for our time on the DigitalHealth.London Accelerator, the team’s support in helping us develop our evidence generation strategy has been pivotal to our growth.”Dr Dafydd Loughran, CEO, Concentric Health
Patients Know Best
Humber Coast and Vale ICS, in collaboration with Patients Know Best, will be looking at improving processes for digital prehabilitation, preoperative assessment, shared decision making and consent. The new approach will utilise clinician time more effectively through the use of remote consultation, pre-op assessments and patient recovery monitoring. The aim of the initiative is to ultimately, create a more patient-centred journey that is more accessible and intuitive.
getUBetter, DrDoctor, Ampersand Health, Concentric Health and Patients Know Best are alumni of the DigitalHealth.London Accelerator programme. DrDoctor and Ampersand Health are alumni companies of the DigitalHealth.London Accelerator programme.
The DigitalHealth.London Accelerator is a collaborative programme funded by two of London’s Academic Health Science Networks – UCL Partners, and the Health Innovation Network, as well as MedCity, CW+ and receives match funding from the European Regional Development Fund.